Boule Con-Diff Tri-Level Multi-Parameter Assayed Hematology Control, used for in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments.
Published April 16, 2014 · Recall initiated: February 24, 2013
Summary
FDA records medical device Class II recall Z-1436-2014, published April 16, 2014 and initiated February 24, 2013. Recalling firm: Clinical Diagnostic Solutions; Status: Terminated; Reported quantity: 3,540; Lot: Product Part Number: 501-605 Lot# 1311-682 Exp. 3/26/2014 501-607 Lot# 1311-683, 1311-684 Exp. 3/26/2014 501-608 Lot# 1311-683 Exp. 3/26/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Elevated MCV results on the 1311-682, 1311-683, and 1311-684 lots.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Clinical Diagnostic Solutions
- Distributor
- Worldwide Distribution: USA Nationwide and the countries of IVORY COAST, MEXICO, and Philippines.
- Lot
- Product Part Number: 501-605 Lot# 1311-682 Exp. 3/26/2014 501-607 Lot# 1311-683, 1311-684 Exp. 3/26/2014 501-608 Lot# 1311-683 Exp. 3/26/2014
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA7mm Drain Kit Flat 3/4 Perforated with 100ml S-Vac Bulb Evacuator, Sterile (10/case) 10 FR Drain Kit 3/4April 16, 2014
- FDAGLOBAL® Anchor Peg Glenoid Plus (APG+) 2.5MM Breakaway Guide Pin Part # 2230-00-019, Non-Sterile, DePuy,April 16, 2014
- FDABoule Con Diff US Tri Pack, 6 Vials. For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
- FDABoule Con-Diff Hematology Control 9 vials. For in vitro diagnostic use as a control to monitor the performanceNovember 14, 2012
- FDABoule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
- FDABoule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
Questions about this recall
Was Boule Con-Diff Tri-Level Multi-Parameter Assayed Hematology Control, used for in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments. recalled?
Yes. FDA published recall Z-1436-2014 on April 16, 2014. Reported hazard: Elevated MCV results on the 1311-682, 1311-683, and 1311-684 lots.
What should I do if I have this product?
Voluntary: Firm initiated · Letter